Cancer cells have developed sophisticated mechanisms to manipulate the immune system's regulatory network, particularly through the amplification of immune checkpoint pathways like the programmed cell death protein-1 (PD-1) / programmed death ligand-1 (PD-L1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4). This evidence concerns the gene PDCD1 and cancer.